106 related articles for article (PubMed ID: 15049938)
1. A novel per-oral insulin formulation: proof of concept study in non-diabetic subjects.
Kidron M; Dinh S; Menachem Y; Abbas R; Variano B; Goldberg M; Arbit E; Bar-On H
Diabet Med; 2004 Apr; 21(4):354-7. PubMed ID: 15049938
[TBL] [Abstract][Full Text] [Related]
2. Oral spray insulin in treatment of type 2 diabetes: a comparison of efficacy of the oral spray insulin (Oralin) with subcutaneous (SC) insulin injection, a proof of concept study.
Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P
Diabetes Metab Res Rev; 2004; 20(6):472-8. PubMed ID: 15386822
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. [Studies on gastrointestinal absorption enhancement effect and mechanism of sodium N-[8-(2-hydroxybenzyl)amino] caprylate to insulin solution].
Qi R; Ping QN; Zhao W
Yao Xue Xue Bao; 2003 Dec; 38(12):953-6. PubMed ID: 15040094
[TBL] [Abstract][Full Text] [Related]
5. Effects of absorption promoters on insulin absorption through colon-targeted delivery.
Katsuma M; Watanabe S; Kawai H; Takemura S; Sako K
Int J Pharm; 2006 Jan; 307(2):156-62. PubMed ID: 16289574
[TBL] [Abstract][Full Text] [Related]
6. Effect of hormone therapy on the enteroinsular axis.
Sztefko K; Rogatko I; Milewicz T; Józef K; Tomasik PJ; Szafran Z
Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
[TBL] [Abstract][Full Text] [Related]
7. A study of the comparative safety and efficacy of neutral soluble human (semi-synthetic) and porcine monocomponent insulin in non-diabetic subjects.
Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG; Vølund A; Alberti KG; Home PD
Diabete Metab; 1982 Jun; 8(2):155-8. PubMed ID: 7049781
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
9. [The enhancing effect of tomato lectin modified liposomes of insulin on oral absorption in mice].
Zhang N; Ping QN; Xu WF
Yao Xue Xue Bao; 2004 May; 39(5):380-4. PubMed ID: 15338884
[TBL] [Abstract][Full Text] [Related]
10. A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats.
Cilek A; Celebi N; Tirnaksiz F; Tay A
Int J Pharm; 2005 Jul; 298(1):176-85. PubMed ID: 15950411
[TBL] [Abstract][Full Text] [Related]
11. Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes.
Albareda M; Rigla M; Rodríguez-Espinosa J; Caballero A; Chico A; Cabezas R; Carreras G; Pérez A
Diabetes Res Clin Pract; 2005 Jun; 68(3):202-6. PubMed ID: 15936461
[TBL] [Abstract][Full Text] [Related]
12. Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects.
Steinert RE; Poller B; Castelli MC; Friedman K; Huber AR; Drewe J; Beglinger C
Clin Pharmacol Ther; 2009 Dec; 86(6):644-50. PubMed ID: 19727071
[TBL] [Abstract][Full Text] [Related]
13. [Enhancing effect of Ulex europaeus agglutinin I modified liposomes on oral insulin absorption in mice].
Zhang N; Ping QN; Xu WF
Yao Xue Xue Bao; 2004 Dec; 39(12):1006-10. PubMed ID: 15813031
[TBL] [Abstract][Full Text] [Related]
14. Oral heparin (Emisphere).
Dunn A
IDrugs; 2000 Jul; 3(7):817-24. PubMed ID: 16080057
[TBL] [Abstract][Full Text] [Related]
15. Effects of fatty ethers and stearic acid on the gastrointestinal absorption of insulin.
Guzmán A; García R
P R Health Sci J; 1990 Aug; 9(2):155-9. PubMed ID: 2077554
[TBL] [Abstract][Full Text] [Related]
16. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
Rosak C; Hofmann U; Paulwitz O
Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
[TBL] [Abstract][Full Text] [Related]
17. Increase of insulin sensitivity by stevioside in fructose-rich chow-fed rats.
Chang JC; Wu MC; Liu IM; Cheng JT
Horm Metab Res; 2005 Oct; 37(10):610-6. PubMed ID: 16278783
[TBL] [Abstract][Full Text] [Related]
18. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
[TBL] [Abstract][Full Text] [Related]
19. Effect of orally administered phenylalanine with and without glucose on insulin, glucagon and glucose concentrations.
Nuttall FQ; Schweim KJ; Gannon MC
Horm Metab Res; 2006 Aug; 38(8):518-23. PubMed ID: 16941278
[TBL] [Abstract][Full Text] [Related]
20. Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study.
Campioni M; Toffolo G; Shuster LT; Service FJ; Rizza RA; Cobelli C
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E54-60. PubMed ID: 16868229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
